The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis
Clinical trial NCT03129126 · COMPLETED
Trial details
- NCT number
- NCT03129126
- Sponsor
- Lipella Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2023-08-21
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.